What I do at MMV:
My role as Director, Clinical Sciences within the Product Development team is to lead the development of clinical strategy and clinical study design for early and late phase projects. I am also involved in writing clinical documents, data analysis and interpretation to ensure efficient and effective clinical development of antimalarials across MMV’s portfolio. I am also co-leading the Malaria in Mothers and Babies (MiMBa) initiative designed to accelerate discovery, development and delivery of appropriate antimalarial options for women who are of reproductive potential, pregnant, or breastfeeding.
Why I work at MMV:
I grew up in malaria-endemic countries and have always been motivated and committed to improving the health and lives of vulnerable populations at risk of infectious diseases. MMV’s mission resonates with me and I joined MMV to contribute to developing new effective and affordable treatments to hopefully eradicate this terrible disease.
More about me:
I am a PharmD by training, specialized in clinical development of molecules from first-in-man to post-approval stage with strong expertise in clinical pharmacology, PK/PD and broad knowledge in formulation and regulatory affairs. Over the last 15 years I had the opportunity to lead early phase programmes, clinical development strategies and clinical pharmacology trials in diverse therapeutic areas in the pharmaceutical industry and in a not-for profit organization.
Ask me about:
Drug development, combinations, clinical trials, development in special populations e.g. pediatrics and pregnant women, clinical pharmacology, PKPD and PBPK. On a more personal note, you can ask me about Africa…its people, its music, its pulse, and its energy!